Phase 1a/1b Trial of Exercise Treatment in Hormone Receptor-Positive Metastatic Breast Cancer

Grant

Date/time Interval

  • April 3, 2019 - March 31, 2024
  • Total Award Amount

  • 20889.00
  • Direct Costs

  • 14067.00
  • Sponsor Award Id

  • BD525521
  • Contributor

  • Wendy Demark-Wahnefried Ph.D.   Principal Investigator